{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T17:04:38Z","timestamp":1763226278683},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T00:00:00Z","timestamp":1434326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0130166","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T18:32:36Z","timestamp":1434393156000},"page":"e0130166","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide"],"prefix":"10.1371","volume":"10","author":[{"given":"Annalisa","family":"Borghini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Nacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bellando-Randone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Ibba-Manneschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,15]]},"reference":[{"key":"ref1","first-page":"198","article-title":"Systemic sclerosis: an update","volume":"66","author":"J Varga","year":"2008","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"A Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"J Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"L Chung","year":"2006","journal-title":"Clin Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"M Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2010.104","article-title":"Assessing microvascular changes in systemic sclerosis diagnosis and management","volume":"6","author":"M Cutolo","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00393-004-0673-5","article-title":"Nailfold video-capillaroscopy in systemic sclerosis","volume":"63","author":"M Cutolo","year":"2004","journal-title":"Z Rheumatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"P Carmeliet","year":"2000","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"W Risau","year":"1997","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","article-title":"Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis","volume":"14","author":"M Manetti","year":"2010","journal-title":"J Cell Mol Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts","volume":"14","author":"BJ Rabquer","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"M Manetti","year":"2011","journal-title":"Trends Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/annrheumdis-2011-200143","article-title":"Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis","volume":"71","author":"J Avouac","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/ar4349","article-title":"Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis","volume":"15","author":"M Manetti","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage","volume":"71","author":"M Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2012-203183","article-title":"Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis","volume":"72","author":"M Manetti","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar2002","article-title":"A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients","volume":"8","author":"B Giusti","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"BJ Rabquer","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/art.22263","article-title":"Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells","volume":"54","author":"F Margheri","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/art.27522","article-title":"Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12","volume":"62","author":"F Margheri","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/jcmm.12105","article-title":"Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma","volume":"17","author":"Y Wang","year":"2013","journal-title":"J Cell Mol Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"M Manetti","year":"2011","journal-title":"Circ Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"M Kuwana","year":"2004","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/art.38326","article-title":"Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis","volume":"66","author":"M Kuwana","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1002\/art.30536","article-title":"Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells","volume":"63","author":"J Avouac","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref26","first-page":"175","article-title":"Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis","volume":"28","author":"Y Yamaguchi","year":"2013","journal-title":"Histol Histopathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?","volume":"3","author":"JN Fleming","year":"2008","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"S Guiducci","year":"2010","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.2007.082495","article-title":"Autologous stem cell transplantation improves microcirculation in systemic sclerosis","volume":"68","author":"I Miniati","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s10067-012-2074-5","article-title":"Bosentan fosters microvascular de-remodelling in systemic sclerosis","volume":"31","author":"S Guiducci","year":"2012","journal-title":"Clin Rheumatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.120416","article-title":"Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis","volume":"40","author":"M Cutolo","year":"2013","journal-title":"J Rheumatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10067-008-1058-y","article-title":"Cyclophosphamide treatment improves microvessel damage in systemic sclerosis","volume":"28","author":"P Caramaschi","year":"2009","journal-title":"Clin Rheumatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4270","article-title":"Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide","volume":"15","author":"M Villano","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"F van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref35","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"EC LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/art.22861","article-title":"Antiangiogenic plasma activity in patients with systemic sclerosis","volume":"56","author":"MJ Mulligan-Kehoe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10067-005-0041-0","article-title":"Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis","volume":"25","author":"P Ostoji\u0107","year":"2006","journal-title":"Clin Rheumatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mvr.2013.06.003","article-title":"Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database","volume":"89","author":"F Ingegnoli","year":"2013","journal-title":"Microvasc Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"FM Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1756-185X.12130","article-title":"Dysregulation of angiogenic homeostasis in systemic sclerosis","volume":"16","author":"HM Farouk","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"ref41","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis","volume":"29","author":"V Riccieri","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.38953","article-title":"Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis","volume":"67","author":"Y Shirai","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.2000.01115.x","article-title":"Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis","volume":"119","author":"H Ihn","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1183\/09031936.00181410","article-title":"Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma","volume":"39","author":"H Dib","year":"2012","journal-title":"Eur Respir J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.2008.102400","article-title":"Anti-endothelial cell antibodies in systemic sclerosis","volume":"69","author":"C Mihai","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1529-0131(200011)43:11<2464::AID-ANR13>3.0.CO;2-F","article-title":"Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles","volume":"43","author":"FK Tan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4049\/jimmunol.163.2.1066","article-title":"Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases","volume":"163","author":"FK Tan","year":"1999","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"DP Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.09-0108","article-title":"Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study","volume":"136","author":"J Goldin","year":"2009","journal-title":"Chest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-2007-985612","article-title":"Advances in immunosuppressive therapy","volume":"28","author":"W Marder","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/j.1582-4934.2009.00810.x","article-title":"Immune cells and angiogenesis","volume":"13","author":"D Ribatti","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/1523-1747.ep12260139","article-title":"Lowered angiogenic capability of peripheral blood lymphocytes in progressive systemic sclerosis (scleroderma)","volume":"82","author":"MJ Kaminski","year":"1984","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0090-1229(92)90193-R","article-title":"Decreased monocyte-mediated angiogenesis in scleroderma","volume":"64","author":"AE Koch","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0090-1229(86)90088-7","article-title":"Human monocyte modulation of endothelial cells and fibroblast growth: possible mechanism for fibrosis","volume":"39","author":"MB Kahaleh","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/art.1780281009","article-title":"Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis","volume":"28","author":"S Majewski","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"ref56","first-page":"S245","article-title":"Role of alpha v integrins during angiogenesis","volume":"6","author":"BP Eliceiri","year":"2000","journal-title":"Cancer J"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"C977","DOI":"10.1152\/ajpcell.00377.2009","article-title":"Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells","volume":"299","author":"B Mariko","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/rheumatology\/keq259","article-title":"Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis","volume":"49","author":"Y Furuya","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3899\/jrheum.080516","article-title":"Abnormalities in the regulators of angiogenesis in patients with scleroderma","volume":"36","author":"LK Hummers","year":"2009","journal-title":"J Rheumatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/emboj\/18.16.4414","article-title":"Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding","volume":"18","author":"N Yamaguchi","year":"1999","journal-title":"EMBO J"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"L Lamalice","year":"2007","journal-title":"Circ Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"A Leask","year":"2004","journal-title":"FASEB J"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1067\/msy.2002.125304","article-title":"Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase","volume":"132","author":"KM Hyman","year":"2002","journal-title":"Surgery"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"L825","DOI":"10.1152\/ajplung.90307.2008","article-title":"Transforming growth factor-beta1 causes pulmonary microvascular endothelial cell apoptosis via ALK5","volume":"296","author":"Q Lu","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0130166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T13:01:13Z","timestamp":1691758873000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0130166"}},"subtitle":[],"editor":[{"given":"Domenico","family":"Ribatti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,15]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0130166","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,15]]}}}